awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47104104-83D2CBD0-AC41-4112-8BD7-85F23BBC8E8B
Q47104104-83D2CBD0-AC41-4112-8BD7-85F23BBC8E8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47104104-83D2CBD0-AC41-4112-8BD7-85F23BBC8E8B
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer.
P304
Q47104104-83D2CBD0-AC41-4112-8BD7-85F23BBC8E8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47104104-83D2CBD0-AC41-4112-8BD7-85F23BBC8E8B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7bee242248c8b9edde6a3397864aa6850a8a50c2
P304
217-229
http://www.w3.org/2001/XMLSchema#string